Author:
Kajiwara Ryosuke,Goto Hiroaki,Yokosuka Tomoko,Yanagimachi Masakatsu,Kuroki Fumiko,Yokota Shumpei
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Oncology,Hematology,Pediatrics, Perinatology and Child Health
Reference22 articles.
1. Role of myeloablative therapy in improved outcome for high risk neuroblastoma: review of recent Children's Cancer Group results;Matthay;Eur J Cancer,1995
2. 1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions;Philip;Eur J Cancer,1997
3. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group;Matthay;N Engl J Med,1999
4. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation;Cesaro;Haematologica,2005
5. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation;Carreras;Blood,1998
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献